TransMedics Group, Inc.

NasdaqGM TMDX

TransMedics Group, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024: USD -157.96 M

TransMedics Group, Inc. Capital Expenditure is USD -157.96 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -12.82% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

TransMedics Group, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -140.00 M, a -1,036.31% change year over year.
TransMedics Group, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -12.32 M, a -3,492.13% change year over year.
TransMedics Group, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -343.00 K.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NasdaqGM: TMDX

TransMedics Group, Inc.

CEO	Dr. Waleed H. Hassanein M.D.
IPO Date	May 2, 2019
Location	United States
Headquarters	200 Minuteman Road
Employees	584
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Key trends

Past 5 years